Invitrotek ltd. Sti. (Istanbul, turkey) and pronto diagnostics ltd. (Tel aviv, israel) will collaborate in developing an assay, based on the targeted next generation sequencing to detect mutations in all thalassemia cases.
The aim is to place healthy hepatic cells into biodegradable biopolymers (such as poly-lactide-co-glycolide), implant them into laboratory animals and demonstrate that the cells survive and function in these animals.
To develop 'cancer microarray cgh kit' for ovarian and prostate cancer for molecular caryotyping from bac dna clones in order to reduce the cost of analysis of each single region and make the technology widely usable in research and medical institutions.
The oral cavity is a unique organ and an entry gate to the whole body. The oralgerd project aims at developing a generic electronic intra-oral technological platform attached to a tooth for various applications such as gerd diagnostics, drug delivery, body health monitoring, and more.
Development of rapamycin eluting stents based on crystallization of the drug onto stent surface aims to develop a crystalline carrier-free coating of rapamycin onto stents which will keep the original metallic stent in the body after the drug has been released
The need of growth systems capable of growing cells in physiological 3d culture for therapeutic applications is rapidly increasing. The purpose is the development of novel technology that will allow the growth of 3d cells & tissue cultures in disposable controlled bioreactors system.
To develop a genetic screening panel and its bioinformatic analysis software in order to detect mutations associated with hypertrophic cardiomyopathy. Required experimental methods and analysis pipeline will be developed.
The aim of the proposed study is to develop quince seed-stem cell suspension cultures, which are synthesizing high level of mucilage and producing enhanced polyphenolics compounds via biotechnological and mirna-based metabolic engineering approaches.